Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Aurora Kinase B Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Aurora Kinase B market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Aurora Kinase B in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Aurora Kinase B market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
AbbVie Inc
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
AstraZeneca Plc
Chipscreen Biosciences Ltd
Cielo Therapeutics Inc
Sanofi
Sareum Holdings Plc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AZD-2811
CS-2164
Danusertib
Ilorasertib
NMI-900
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Anaplastic Large Cell Lymphoma
Kidney Cancer
Lung Cancer
Prostate Cancer
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Aurora Kinase B Market Research Report 2017
1 Aurora Kinase B Market Overview
1.1 Product Overview and Scope of Aurora Kinase B
1.2 Aurora Kinase B Segment by Type (Product Category)
1.2.1 Global Aurora Kinase B Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Aurora Kinase B Production Market Share by Type (Product Category) in 2016
1.2.3 AZD-2811
1.2.4 CS-2164
1.2.5 Danusertib
1.2.6 Ilorasertib
1.2.7 NMI-900
1.2.8 Others
1.3 Global Aurora Kinase B Segment by Application
1.3.1 Aurora Kinase B Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Anaplastic Large Cell Lymphoma
1.3.3 Kidney Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Global Aurora Kinase B Market by Region (2012-2022)
1.4.1 Global Aurora Kinase B Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Aurora Kinase B (2012-2022)
1.5.1 Global Aurora Kinase B Revenue Status and Outlook (2012-2022)
1.5.2 Global Aurora Kinase B Capacity, Production Status and Outlook (2012-2022)

2 Global Aurora Kinase B Market Competition by Manufacturers
2.1 Global Aurora Kinase B Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Aurora Kinase B Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Aurora Kinase B Production and Share by Manufacturers (2012-2017)
2.2 Global Aurora Kinase B Revenue and Share by Manufacturers (2012-2017)
2.3 Global Aurora Kinase B Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Aurora Kinase B Manufacturing Base Distribution, Sales Area and Product Type
2.5 Aurora Kinase B Market Competitive Situation and Trends
2.5.1 Aurora Kinase B Market Concentration Rate
2.5.2 Aurora Kinase B Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Aurora Kinase B Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Aurora Kinase B Capacity and Market Share by Region (2012-2017)
3.2 Global Aurora Kinase B Production and Market Share by Region (2012-2017)
3.3 Global Aurora Kinase B Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Aurora Kinase B Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Aurora Kinase B Consumption by Region (2012-2017)
4.2 North America Aurora Kinase B Production, Consumption, Export, Import (2012-2017)
4.3 Europe Aurora Kinase B Production, Consumption, Export, Import (2012-2017)
4.4 China Aurora Kinase B Production, Consumption, Export, Import (2012-2017)
4.5 Japan Aurora Kinase B Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Aurora Kinase B Production, Consumption, Export, Import (2012-2017)
4.7 India Aurora Kinase B Production, Consumption, Export, Import (2012-2017)

5 Global Aurora Kinase B Production, Revenue (Value), Price Trend by Type
5.1 Global Aurora Kinase B Production and Market Share by Type (2012-2017)
5.2 Global Aurora Kinase B Revenue and Market Share by Type (2012-2017)
5.3 Global Aurora Kinase B Price by Type (2012-2017)
5.4 Global Aurora Kinase B Production Growth by Type (2012-2017)

6 Global Aurora Kinase B Market Analysis by Application
6.1 Global Aurora Kinase B Consumption and Market Share by Application (2012-2017)
6.2 Global Aurora Kinase B Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Aurora Kinase B Manufacturers Profiles/Analysis
7.1 AbbVie Inc
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Aurora Kinase B Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AbbVie Inc Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Advenchen Laboratories LLC
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Aurora Kinase B Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Advenchen Laboratories LLC Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Aeterna Zentaris Inc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Aurora Kinase B Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Aeterna Zentaris Inc Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Amgen Inc
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Aurora Kinase B Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Amgen Inc Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 AstraZeneca Plc
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Aurora Kinase B Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 AstraZeneca Plc Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Chipscreen Biosciences Ltd
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Aurora Kinase B Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Cielo Therapeutics Inc
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Aurora Kinase B Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Cielo Therapeutics Inc Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Sanofi
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Aurora Kinase B Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Sanofi Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Sareum Holdings Plc
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Aurora Kinase B Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Sareum Holdings Plc Aurora Kinase B Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview

8 Aurora Kinase B Manufacturing Cost Analysis
8.1 Aurora Kinase B Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Aurora Kinase B

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Aurora Kinase B Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Aurora Kinase B Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Aurora Kinase B Market Forecast (2017-2022)
12.1 Global Aurora Kinase B Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Aurora Kinase B Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Aurora Kinase B Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Aurora Kinase B Price and Trend Forecast (2017-2022)
12.2 Global Aurora Kinase B Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Aurora Kinase B Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Aurora Kinase B Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Aurora Kinase B Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Aurora Kinase B Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Aurora Kinase B Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Aurora Kinase B Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Aurora Kinase B Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Aurora Kinase B Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37947

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 103

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)